All
Current
Realized
Afton Scientific
Acquired: 2024|Status: current

Afton Scientific (“Afton”) is a leading contract, development and manufacturing organization (“CDMO”) dedicated to sterile manufacturing of injectable pharmaceuticals. Afton specializes in sterile injectable drug manufacturing as well as providing pre-sterilized vials and kits.  The Company performs aseptic fill-finish for products ranging from pre-clinical through commercial-scale manufacturing across various therapeutic areas. Afton is headquartered in Charlottesville, VA.

Visit Website
AVS Bio
Acquired: 2022|Status: current

Headquartered in Norwich, CT, AVS Bio is global provider of specific pathogen free (“SPF”) eggs and adjacent laboratory products and services that support the development and manufacturing of vaccines, therapeutics, and other biologics used for human and animal health. Prior to its acquisition by Arlington, the Company operated as a subsidiary of Charles River Laboratories (NYSE:CRL). The Company currently employs ~250 employees across 20+ facilities in Connecticut, New York, Illinois, Missouri, and Europe.

 

Visit Website
Millstone Medical Outsourcing
Acquired: 2021|Status: current

Headquartered in Fall River, MA, Millstone Medical Outsourcing is a provider of comprehensive solutions and quality-critical services for the medical industry, including post-manufacturing services, supply chain and logistics and laboratory testing. Millstone’s post-manufacturing services include sterile packaging, advanced inspection, validation engineering, and clean room services. The Company’s supply chain and logistics services include specialized distribution, cold chain logistics, and inventory and returns management. Laboratory testing services include bacterial endotoxin, bioburden, EO residual, environmental monitoring, sterility, microbiology, cytotoxicity, accelerated aging, and other regulatory testing for medical device and pharmaceutical customers. Millstone currently employs over 560 employees across four facilities in Fall River, MA, Olive Branch, MS, Willington, CT and West Warwick, RI.

Visit Website
Everest
Acquired: 2020|Status: current

Everest Clinical Research Corporation (“Everest”) is a full-service contract research organization (“CRO”) providing a broad range of expertise-based clinical research services to worldwide pharmaceutical, biotechnology, and medical device industries. Everest serves some of the best-known companies and works with many of the most advanced drugs, biologics, and medical devices in development today. Founded in 2004, Everest has a strong foundation as a statistical and data management center of excellence. Building on this foundation, Everest has successfully developed and established itself as a full-service CRO. Operating primarily in North America, with headquarters located in Toronto, Ontario, Canada, a second office in Little Falls, New Jersey, USA and a third office in Shanghai, China, Everest is known in the industry for its high quality deliverables, superior customer service, and flexibility in meeting clients’ needs.

Visit Website
Riverpoint Medical
Acquired: 2019|Status: current

Headquartered in Portland, Oregon, Riverpoint Medical is a leading US-based developer, designer, and manufacturer of medical devices focused on advanced bio-medical textile technologies. Riverpoint’s wound closure products include a broad portfolio of high-quality bio-absorbable and non-absorbable sutures for the surgical and animal health markets. The Company’s robust sports medicine offering includes implants and high strength fiber solutions utilizing its proprietary ultra-high molecular weight polyethylene (UHMWPE) non-absorbable suture (HS Fiber®). Additionally, Riverpoint is a leading provider of cordless LED surgical headlights (MedLED®) and offers a suite of brachytherapy products for the oncology market.

Visit Website
GRAM
Acquired: 2017|Status: current

Grand River Aseptic Manufacturing (GRAM), is a parenteral contract manufacturing organization that delivers customized solutions to meet clients’ fill and finish needs from development through commercialization. With capabilities for biologics as well as controlled substances, GRAM’s expert project managers and modern facilities support pharmaceutical development and cGMP manufacturing, analytical testing and regulatory filing.

Visit Website
Avalign
Acquired: 2015|Status: realized

Avalign is a premier full-service precision manufacturer of implants and instruments, specialty instrumentation, cutting instruments, and delivery systems to the orthopedic medical device and specialty surgical markets.  Avalign offers its OEM partners a broad portfolio of manufacturing solutions and extensive engineering design, development, and project management capabilities from concept to launch.  Avalign has an established reputation for consistent and sophisticated quality systems, flexible capacity capabilities, and superior customer service.

In 2018, Avalign Technologies was sold to Linden Capital Partners.

Ontario Systems
Acquired: 2015|Status: realized

Ontario Systems, LLC (“Ontario Systems”) is a leading provider of revenue cycle management and accounts receivable management software for the healthcare, government and outsourced accounts receivable management industries. Offering a full portfolio of software and solutions, Ontario Systems’ customers include three of the top six health systems in the U.S. and nine of the ten largest accounts receivable management companies, with approximately 55,000 licensed users in more than 500 locations.

In 2019, Ontario Systems was sold to New Mountain Capital.

Micron Technologies
Acquired: 2013|Status: realized

Micron Technologies (“Micron”) focuses on solving the pharmaceutical industry’s most difficult bio-availability and drug delivery challenges through multiple particle size reduction technologies.

Micron is a leading independent provider of micronization services for solubility enhancement of active pharmaceutical ingredients (“APIs”). Micron maintains state of the art facilities, in the US and UK, offering industry leading capabilities including distinctive containment technology for processing highly potent compounds.

In 2014, Micron was sold to Catalent  (NYSE:CTLT), a provider of advanced delivery technologies and development solutions for drugs and consumer health products.

Visit Website
Cambridge Major Labs
Acquired: 2007|Status: realized

Cambridge Major Laboratories (“CML”) is a leading, global chemistry-based contract research organization (“CRO”) providing comprehensive chemistry outsourcing solutions to a diverse customer base, including some of the world’s largest pharmaceutical, small/mid-sized biotechnology, and generic drug companies. CML offers customers a broad array of chemistry services, delivering a complete life cycle of capabilities including process chemistry, solid state chemistry, analytical services, active pharmaceutical ingredients (“API”) production services and regulatory services. CML is headquartered in Germantown, WI.

In 2012, Cambridge Major Laboratories was sold to American Capital (Nasdaq:ACAS).

AHM
Acquired: 2007|Status: realized

Advanced Health Media (“AHM”) is a leading U.S. provider of meeting logistics, commercial compliance management solutions, and sales force productivity tools for the pharmaceutical industry. AHM has developed and markets a fully-integrated suite of hosted technology solutions and sales support services designed to address the diverse operational and compliance management needs of its clients, including corporate speaker bureau and event management solutions, sales force automation technology, CRM and compliance tracking and reporting systems.

In 2018, AHM was sold to IQVIA (NYSE: IQV), a provider of advanced analytics and technology solutions to the life science industry.